Is there a role of magnetic resonance imaging in deciding to stop anti-tumor necrosis factor treatment in ileal Crohn's disease?

被引：5
|
作者：
Gallego, Jose C. [1 ]
Echarri, Ana [2 ]
机构：
[1] Complexo Hosp Univ Ferrol, Radiol Dept, Av Residencia S-N, Ferrol 15405, Spain
[2] Complexo Hosp Univ Ferrol, Gastroenterol Dept, Ferrol, Spain
来源：
CLINICAL IMAGING | 2017年 / 43卷
关键词：
Crohn's disease; Magnetic resonance imaging; Anti-tumor necrosis factor agents; INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB THERAPY; CLINICAL REMISSION; FOLLOW-UP; DISCONTINUATION; MAINTENANCE; RELAPSE;
D O I：
10.1016/j.clinimag.2017.03.010
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Purpose: This study was performed to assess the ability of magnetic resonance enterography to predict the evolution of patients in whom anti-tumor necrosis factor-alpha therapy was suspended. Methods: A prospective study of patients with ileal Crohn's disease was performed. Results: Twenty-nine patients were included. Patients who later relapsed showed higher magnetic resonance scores than those who did not relapse (4.2 vs. 2.5, respectively; p < 0.02). The area under the receiving-operating characteristics curve was 0.755 when discriminating patients who relapsed. Conclusions: Magnetic resonance enterography should be taken into account when deciding the withdrawal of anti-tumor necrosis factor-alpha in patients with Crohn's disease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：175 / 179
页数：5
相关论文
共 50 条
  • [1] The Role of Oxidative Stress in Anti-tumor Necrosis Factor Antibody Treatment in Crohn's Disease
    Kupcova, V.
    Turecky, L.
    Uhlikova, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (30) : 5226 - 5231
  • [2] A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease
    Papamichael, Konstantinos
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 493 - 501
  • [3] Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
    Netz, Uri
    Carter, Jane Victoria
    Eichenberger, Maurice Robert
    Dryden, Gerald Wayne
    Pan, Jianmin
    Rai, Shesh Nath
    Galandiuk, Susan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (27) : 4958 - 4967
  • [4] Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies
    Eder, Piotr
    Michalak, Michal
    Katulska, Katarzyna
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Stawczyk-Eder, Kamila
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Linke, Krzysztof
    SCIENTIFIC REPORTS, 2015, 5
  • [5] Tacrolimus Salvage in Anti-Tumor Necrosis Factor Antibody Treatment-Refractory Crohn's Disease
    Gerich, Mark E.
    Pardi, Darrell S.
    Bruining, David H.
    Kammer, Patricia P.
    Becker, Brenda D.
    Tremaine, William T.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1107 - 1111
  • [6] Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Patil, Seema A.
    Flasar, Mark H.
    Lin, Jay
    Lingohr-Smith, Melissa
    Skup, Martha
    Wang, Song
    Chao, Jingdong
    Cross, Raymond K.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (01) : 60 - 67
  • [7] Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease
    Nguyen, Douglas L.
    Flores, Sarah
    Sassi, Kareem
    Bechtold, Matthew L.
    Nguyen, Emily T.
    Parekh, Nimisha K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 147 - 154
  • [8] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [9] Use of Anti-Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease
    Shivashankar, Raina
    Pardi, Darrell S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (03) : 589 - +
  • [10] The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease
    Dotlacil, Vojtech
    Bronsky, Jiri
    Hradsky, Ondrej
    Frybova, Barbora
    Coufal, Stepan
    Skaba, Richard
    Rygl, Michal
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2020, 30 (01) : 27 - 32
12345